- category:Business
Business
Bausch + Lomb may be acquiring InflammX Therapeutics
Option agreement indicates B+L intends to purchase the biotech company and its orally-administered therapeutic under clinical investigation for retinal diseases.
Business
HelpMeSee expanding simulation-based surgical training to two new locations
New training sites in Los Angeles and Chicago will offer four categories of on-demand learning and hands-on experience in a safe, repeatable, and realistic environment.
Business
VisiRose raises $3M to advance RB-PDAT therapeutic toward regulatory approval
Funding will support ongoing clinical development of photodynamic therapy candidate for infectious keratitis and future IND submission to FDA.
Business
WAVE Eye Care launches as new specialty contact lens division
EyePrint Prosthetics, Advanced Vision Technologies, and WAVE Contact Lens System join forces to offer unique and customized specialty contact lens offerings.
Business
Bausch + Lomb adds to glaucoma and GA pipeline with two deals
Latest developments involve the acquisition of WhiteCap Biosciences and its GA candidate, as well as a partnership with RNAi-focused City Therapeutics.
Business
Aviceda raises $207M to support phase 3 testing of AVD-104 for GA
Financing will support advancement of AVD-104, designed to target a specific area of the innate immune response relating to AMD.
Business
Regeneron reportedly purchases British biotech Oxular
Announcement made by CEO seemingly confirms acquisition of the retinal disease company and its lead candidate: OXU-001, a sustained-release dexamethasone formulation for DME.
Business
Tenpoint and Visus Therapeutics merge with plans for ophthalmic therapeutic advancements
Newly-combined Tenpoint Therapeutics, Ltd includes a pipeline featuring BRIMOCHOL PF, a once-daily eye drop for presbyopia targeting an NDA filing in 2025.
Business
Bausch + Lomb purchases Elios Vision
Acquisition includes the ELIOS procedure, an excimer laser-based and implant-free MIGS technology performed during cataract surgery for glaucoma treatment.
Business
SCOPE Health and CEVR partner to develop DED and OSD tech
Collaboration will focus on establishing a new standard of care for ocular surface disease to preserve and enhance vision across the globe.
Business
Avant Technologies and Ainnova to advance low-cost retinal camera with AI software
Newly-formed joint company will develop an exclusive retinal imaging camera to be integrated into Ainnova’s disease detection digital platform.
Business
Johnson & Johnson names industry exec as president of Vision Care
Shawn Millerick is the new president of the Americas division, while Erin Powers is now leading as VP of the North American Surgical Vision business.
Business
AOA Excel endorses Barti Software in first-ever eyecare EHR investment
Platform targets increased practice efficiency via quicker reimbursements and AI-enabled capabilities like real-time charting and appointment scheduling.
Business
Harrow launches initiative for expanded access, price cuts of branded products
The company is partnering with GoodRx to provide patients with discounts on select ophthalmic products.
Business
Harrow partners with Asembia for expanded branded ophthalmic product access
Partnership aims to simplify the prescribing process and ensure accessibility and affordability for patients; company also reports new Medicare coverage for VEVYE.
Business
AlloVir and Kalaris to form retinal disease-focused company
Merger focuses on advancing clinical development of TH103, a novel differentiated anti-VEGF investigational therapy for nAMD.
Business
Tarsus names Elizabeth Yeu, MD, as new chief medical officer
Dr. Yeu will lead the company’s new medical organization as it continues the rollout of XDEMVY for Demodex blepharitis.
Business
Grifols and HHS partner on preclinical testing of OSIG drops for mustard gas eye injury
Collaboration involves evaluating investigational immunoglobulin eye drop for DED, with the potential to become a groundbreaking treatment.
Business
Bausch + Lomb names leading ophthalmologist as strategic medical advisor
Industry veteran Cathleen McCabe, MD, will consult on the company’s expanding product portfolio and serve as liaison to the global ECP community.
Business